Jazz Pharmaceuticals plc (JAZZ) Free cash flow 2018–2025
Jazz Pharmaceuticals plc (JAZZ) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$1.3BFY2025 · since FY2018: $778.5M → $1.3B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.3B | -4.5% |
| FY2024 | $1.4B | +27.1% |
| FY2023 | $1.1B | -14.1% |
| FY2022 | $1.2B | +65.5% |
| FY2021 | $750.9M | -15.1% |
| FY2020 | $884.6M | +20.2% |
| FY2019 | $736.3M | -5.4% |
| FY2018 | $778.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice